anamarija Štafa ph.d. laboratory for biology and microbial genetics department of biochemical...
TRANSCRIPT
Genetic side-effects during gene replacement in
yeast Saccharomyces cerevisiae
Anamarija Štafa Ph.D.
Laboratory for Biology and Microbial GeneticsDepartment of Biochemical Engineering
Faculty of Food Technology and BiotechnologyUniversity of Zagreb
2
Svetec group
”Palindromes in genomes and mechanisms of gene targeting in yeast”
Yeast Saccharomyces cerevisiae• first eukaryotic organism sequenced (Goffeau et al., 1996)
• suitable for genetic manipulation - first eukaryotic organism stabily transformed with exogenous non-replicative DNA, by integration into the genome, via homologous recombination (Hinnen et al., 1978)
• wide application in biotechnology
• production of beer, wine, strong alcohol and dough (classical biotechnology)
• production of insulin, glucagon, somatotropin, interferon and vaccines (rDNA technology)
3
Introduction to gene targeting and ends-out recombination
• gene targeting is a genetic technique that uses homologous recombination to modify an endogenous gene
• ends point away from each other (ends-out recombination)
• the transforming DNA fragment is supposed to replace targeted gene (gene replacement)
genomic allele after gene replacement
genomic allele gene X
• ends-out recombination is used for:• inactivation of genes (knock-out mutants)• correction of mutations (knock-in mutants = gene therapy)
the transforming DNA fragment with selectable marker
selectable marker
flanking homologies(addresses)
4
Introduction to gene targeting and ends-out recombination
• yeast Saccharomyces cerevisiae (Bailis and Maines, 1996)
• proteins involved in homologous recombination are evolutionary conserved among eukaryotes (Karpenshif and Bernstein, 2012; Krejci et al., 2012; Aggarwal and Brosh, 2012)
• successful ends-out recombination • phylamentous fungi (Paietta and Marzluf, 1985)
• Trypanosoma brucei (Gibson et al., 1996)
• Physcomitrella patens (Schaefer and Zyrd, 1996)
• DT40 cell line (Buerstedde and Takeda, 1991)
5
The proportion of targeted events in ends-out assay?
Targeted events60.0 %
Aberrant genetic events40.0 %
Observed in all organisms
analysed so far
8.9 % Random integration of the transforming DNA fragment
Addition of the transforming DNA fragment next to the homology 10.0 %
21.1 % Disomic for the chromosome V*aneuploidy was confirmed by PFGE and FACS
Molecular analysis of transformants by Southern blotting (Svetec et al., 2007)
6
Parameters that influence the proportion of targeted events?
1. length of flanking homologies (Bailis and Maines, 1996)
2. systematic investigation of ends-out recombination (Štafa et al., manuscript in preparation):
• type of gene/genome modification - insertion, replacement, deletion
• transformation method - lithium acetate transformation, spheroplast transformation and electroporation
*aneuploidy was confirmed by PFGE and FACS
7
Take home message
Modifying any region in genome may result in generation of unwanted (aberrant) alterations (disomic
transformants and/or direct and dispersed repetas) that could easily go unnoticed.
It is necessary to use molecular methods to confirm both the presence of modified allele and the
absence of starting (unmodified) allele.
The transforming DNA fragments that insert or replace, rather than delete, result in lower percentage of
aberrant events.
Acknowledgements:
prof. Ivan-Krešimir Svetec Ph.D. FUNDING:
Berislav Lisnić Ph.D.
Marina Miklenić M.Sc.
Bojan Žunar M.Sc. Dekkera/Brettanomyces
Nataša Tomašević
9
Thank you for your attention
10
plasmid isolation
&
restriction
gel purification
of the transforming
fragment
control gel
electophoresis
yeast
transformationreplate transfomants
yeast genomic DNA
isolation & restriction Southern blotting analyse resultsgel electophoresis
TO BE OR NOT TO
BE ....TRANSFORMED?